Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer

類似資料

• Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
  著者:: Smith, Matthew R., 等
  出版事項: (2010)
• Factors associated with vertebral fractures in men treated with androgen deprivation therapy (ADT) for prostate cancer
  著者:: Saylor, Philip J., 等
  出版事項: (2011)
• Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer
  著者:: Smith, Matthew R., 等
  出版事項: (2011)
• Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer
  著者:: Shahinian, Vahakn B., 等
  出版事項: (2013)
• Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
  著者:: Smith, Matthew R., 等
  出版事項: (2009)